Calypte Only Company with Full Menu of Tests.

Support/Resistance
Type Value Conf.
resist. 0.31 2
resist. 0.24 4
resist. 0.23 6
resist. 0.22 8
resist. 0.21 12
resist. 0.20 38
resist. 0.19 10
supp 0.18 12
supp 0.17 2
supp 0.15 6
supp 0.13 14  

Time & Sales
Price Size Exch Time
0.19 1000 AMX 16:00:30
0.18 1000 SNX 15:49:48
0.18 100 PAC 15:49:07
0.18 100 PAC 15:49:07
0.18 100 PAC 15:49:07
0.18 900 PAC 15:49:07
0.18 10000 AMX 15:49:04
0.18 2400 SNX 15:48:57
0.17 3000 AMX 15:38:09
0.18 100 AMX 15:09:37
0.18 100 PAC 15:09:32
0.18 100 PAC 15:09:32
0.18 100 PAC 15:09:32
0.18 100 PAC 15:09:32
0.18 100 PAC 15:09:32
0.18 40600 SNX 15:08:52
0.18 11000 SNX 15:02:01
0.19 1000 AMX 14:39:33
0.18 7100 SNX 14:31:20
0.18 10000 SNX 14:30:27
0.18 95900 SNX 14:16:58
0.18 3000 SNX 13:38:45
0.18 300 SNX 13:30:35
0.18 23300 SNX 13:10:06
0.18 11000 SNX 13:06:01
0.181 1000 SNX 13:05:55
0.18 900 SNX 12:54:17
0.18 100 PAC 12:54:10
0.18 100 PAC 12:54:10
0.18 1500 PAC 12:54:07


der gehandelte durchschnittskurs lag übrigens bei 0,1791$...  

 

 

by: bruzzones2000 (53/California)  11/11/05 03:03 pm
Msg: 11455 of 11456

RK, thank you for your posts with the facts. There are many of us who are long in HIV, have been so for years and who have done our due diligence, following the company for an extended period of time.

The bashers with whom you are engaged on this board have been bashing this stock for over three years. Clearly, any person who claims not to have any financial interest in the company has to have a motive to post negatively day in and day out.

It is also clear they are posting under different screen names, indicative by the amount of time between their posts.

Calypte has had a hard battle upward in the HIV testing research and development field.

Currently, there is only one major competitor with an oral HIV test and they have high production costs as they produce their product domestically. Calypte will be a major competitor to them on the international market due to their strategic goals and the ability to produce the product at one half to to two thirds less than the cost of the competitor.

This will give Calypte the edge in the international market as the domestic market is currently clogged with HIV tests and HIV testing. Where HIV testing "is at" is in the foreign markets.

Right now, the competition is obviously threatened as they recently announced they are going to seek the international markets and are currently marketing in the same markets as Calypte.

So, now you may realize the motive for the bashers posting false information about the stock and their attempts to manipulate the stock price.

Fortunately, Calypte is managed by an international expert who sits on the Board of Directors of one of the world's largest steel companies. The key financier is an extremely successful group of individuals who have been involved with the world's largest oil companies and has had successful ventures in international telecommunications, international sugar refining, oil terminal ventures, international real estate and internet security ventures. They have experience in the regions where the competition is seeking to enter and they have the business savvy to make the company a success. You can bet they have done their due diligence, as well.

Naturally, the competition would be nervous, extremely nervous.

So, you have to ask yourself why the bashers have been here for so long, posting day in and day out, old outdated historical information to dissuade investors.

The answer is obvious...it has to be the competition or the several posters who have been conducting the bashing have some serious personality disorder to make such a serious long term investment in time. Nobody shorts a stock for over three years, especially when the movement has been level for extended periods of time.

Again, thanks for your research and the information you have been putting out to others.

In my opinion, Calypte has been slow but the successes the past six months have been monumental and we are on the edge of something very, very big.

Best to you.


 

denn dann hört das elende gepushe hier endlich auf!!! die zahlen werden alle pusher wieder überführen.

mein tipp: q-3 umsätze zwischen 300.000 - 400.000$ bei deutlichem verlust und DAS BEI DER MARKTKAPITALISIERUNG!!!

caly ist gnadenlos überbewertet. allen pusher-börsenbriefen zum trotz war euer letzter hype auf 0,35$ eine reineverarschung, weil nämlich nichts dahinter steckt, was der rückgang auf unter 0,20$ zeigt, wie von mir angedroht  

Time & Sales  
Price Size     Exch Time
0.19 600     AMX 16:00:33
0.19 100     PAC 15:52:13
0.19 20100     SNX 15:51:45
0.19 15000     SNX 15:43:20
0.19 600     AMX 15:38:08
0.20 2000     SNX 15:37:58
0.20 9000     AMX 15:37:57
0.19 4500     SNX 15:36:48
0.19 6000     SNX 15:24:07
0.20 200     SNX 15:22:31
0.19 6700     NSX 15:21:43
0.19 22500     SNX 14:59:43
0.19 800     SNX 14:28:52
0.19 700     SNX 14:27:06
0.191 100     SNX 14:26:42
0.19 13600     AMX 14:18:58
0.19 10000     AMX 14:18:51
0.19 122400     SNX 14:18:37
0.19 11000     NSX 14:18:24
0.19 15000     NSX 14:18:23
0.19 15000     SNX 14:18:23
0.19 20000     NSX 14:17:54
0.19 20000     SNX 14:17:54
0.19 124100     SNX 14:16:31
0.19 175900     SNX 14:16:31
0.19 25000     SNX 13:59:32
0.19 60000     SNX 13:59:19
0.18 500     NSX 13:43:46
0.18 600     AMX 13:38:16
0.18 5100     SNX 13:38:07  

Support/Resistance
      Type     Value     Conf.§
resist. 0.31 2
resist. 0.24 2
resist. 0.23 20
resist. 0.22 8
resist. 0.21 12
resist. 0.20 40
resist. 0.19 10
supp 0.18 12
supp 0.17 2
supp 0.15 6
supp 0.13 14  

Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy

 

 

ihr nicht doch liebr noch die reissleine ziehen wollt.

wer glaubt denn allen ernstes, dass die q-zahlen gut werden?

meine schätzung_: umsätze zwischen 300.000 - 400.000$ bei einem verlust zwischen 1.000.000 - 1.500.000$...  

 

 

pessimistisch!

broker ist doch auch positiv gestimmt:


   1654. Ich freue mich auf 15.11.2005 o. T.   Brokersince1994   11.11.05 19:42  

und auch du warst doch so hoffnungsfroh:


1648. Moechte endlich meine Weltreise starten ...   Biomedi   09.11.05 10:31  

von den Calypte Aktien finanziert. Das Reisebuero wollte sie (noch)nicht zum Kurs von 3 Euro/Stueck kaufen...  


na siehste, dann kann doch gar nichts mehr schief gehen...  

 

bleiben  

 

CC ? keine Zahlen ?

no conference call tommorrow
by: rkbinion57
Long-Term Sentiment: Hold  11/14/05 11:41 am
Msg: 11548 of 11583

just talkED to Tim's office. NO CONFERENCE CALL TOMMORROW. NONE EXPECTED UNTIL END OF QUARTER. SORRY TO BE THE BEARER OF BAD NEWS.


 

habe das auch gelesen.

Zahlen muß es Morgen geben, was CC angeht ginge ich davon aus, das es auch Morgen den Zahlen folgen sollte..

Vom CC 14.10.2005
R. Gale:
We do look forward to talking to you again and as I and my colleagues have said in mid November we’ll be coming back to you with a more formal presentation of the financial and operational results of the Company, So, thank you very much indeed!


Gruß

C.O
 

Form 10QSB

http://phx.corporate-ir.net/...MueG1sP2lwYWdlPTM3ODYyMzUmcmVwbz10ZW5r




Gruß

C.O  

Cash and cash equivalents at end of period                                              2004: 4,504$  --->2005: 658$  
Total inventory  :  2004:  1,524$   --->2005:  444$      

Kohle alle, Lagerbestände auch fast weg.

Wundert mich nicht, dass es keinen CC gibt.  



Never argue with an idiot -- they drag you down to their level, then beat you with experience.  

;  )  

Aber ich würde jetzt echt die Reißleine ziehen - in 9 Monaten fast die gesamte Kohle verbrannt ohne entsprechende Gegenwerte zu schaffen :-(
In dem Tempo ist Calypte in 2 Monaten pleite.

Selbst wenn jetzt noch ein supa-duba-Großauftrag reinkäme - die haben gar nicht mehr die Kohle und die Materialien um den auszuführen.



Never argue with an idiot -- they drag you down to their level, then beat you with experience.  

bis zur revenue würde Cash vollkommen reichen, ich vertraue Ihm ;  )
also muß jetzt was kommen, nicht umsonst war die ganze mühe...

Many HIV intervention  programs in developing countries are supported by foreign
funding. In the case of funding from the United States, typically through PEPFAR
or USAID,  products  that are not  approved  locally or by the USFDA may be used
provided  they have a waiver  issued by the USAID and CDC.  We do not  currently
have a  USAID  waiver  nor  do we  have  the  requisite  data  to  complete  our
applications at this time. However, it is our intention to pursue a USAID Waiver
as soon as we have  compiled  the  required  data in  terms  of  "manufacturer's
claims" and  independent  trials.  Our China and pending African trials could be
sources of data  adequate in quantity and  performance  to achieve this goal. We
believe that obtaining a USAID waiver is an important  milestone in facilitating
international sales of our rapid tests.
 

dass mich wundert, dass die sich heute noch so gut gehalten haben.

Hört lieber auf den Doc und nehmt die Kohle, solange ihr noch einigermassen was für die Aktien bekommt. Für mich liegen dich am Tropf im Koma. Bis die abnippeln, ist m.E. nur noch ne Frage der Zeit.

Grüße, ZN